Calcium binding protein 2

CABP2
Identifiers
AliasesCABP2, DFNB93, calcium binding protein 2
External IDsOMIM: 607314; MGI: 1352749; GeneCards: CABP2
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_016366
NM_031204
NM_001318496

NM_001160252
NM_001160253
NM_013878

RefSeq (protein)

NP_001305425
NP_057450

NP_001153724
NP_001153725
NP_038906

Location (UCSC)Chr 11: 67.52 – 67.52 MbChr 19: 4.13 – 4.14 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Calcium binding protein 2, also known as CaBP2, is a protein that in humans is encoded by the CABP2 gene.

CaBP2 contain a consensus sequence for N-terminal myristoylation, akin to members of the recoverin subfamily, and undergoes fatty acid acylation in vitro.

Gene

The CABP2 gene comprises 6 exons, spanning approximately 5 kb, and is situated on chromosome 11q13.1.

Function

CaBP2 involves in calcium signaling and regulation. Specifically, CaBP2 is known for its ability to bind calcium ions, acting as a calcium sensor within cells. This interaction with calcium plays a crucial role in various cellular processes, including neurotransmitter release in neurons and modulation of ion channels. CaBP2 is found in the retina and plays a significant role in visual signal processing. It interacts with other proteins, including those involved in the phototransduction cascade, contributing to the regulation of calcium levels in response to light stimuli.

Clinical significance

Moreover, The CaBP2 protein is highly expressed in the cochlea. Non-syndromic autosomal recessive hearing impairment DFNB93, caused by defects in the CABP2 gene. Genetic defects in CABP2 may result in moderate to severe sensorineural hearing impairment.

As of 2021, CaBP2-related non-syndromic hearing impairment has been reported in only a few families worldwide, including those in Iran, Turkey, Pakistan, Italy, and Denmark.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000167791 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000024857 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 Haeseleer F, Sokal I, Verlinde CL, Erdjument-Bromage H, Tempst P, Pronin AN, et al. (January 2000). "Five members of a novel Ca(2+)-binding protein (CABP) subfamily with similarity to calmodulin". The Journal of Biological Chemistry. 275 (2): 1247–1260. doi:10.1074/jbc.275.2.1247. PMC 1364469. PMID 10625670.
  6. ↑ Haynes LP, McCue HV, Burgoyne RD (January 2012). "Evolution and functional diversity of the Calcium Binding Proteins (CaBPs)". Frontiers in Molecular Neuroscience. 5 9. doi:10.3389/fnmol.2012.00009. PMC 3284769. PMID 22375103.
  7. ↑ Williams RJ (2000). "A survey of the Sixth European Symposium on Calcium-binding Proteins". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1498 (2–3): 82–83. doi:10.1016/s0167-4889(00)00116-6. ISSN 0167-4889. PMID 11108951.
  8. ↑ Sinha R, Lee A, Rieke F, Haeseleer F (2016). "Lack of CaBP1/Caldendrin or CaBP2 Leads to Altered Ganglion Cell Responses". eNeuro. 3 (5): ENEURO.0099–16.2016. doi:10.1523/eneuro.0099-16.2016. PMC 5083949. PMID 27822497.
  9. ↑ Yang T, Hu N, Pangršič T, Green S, Hansen M, Lee A (July 2018). "Functions of CaBP1 and CaBP2 in the peripheral auditory system". Hearing Research. 364: 48–58. doi:10.1016/j.heares.2018.04.001. PMC 6954825. PMID 29661613.
  10. ↑ Schrauwen I, Helfmann S, Inagaki A, Predoehl F, Tabatabaiefar MA, Picher MM, et al. (October 2012). "A mutation in CABP2, expressed in cochlear hair cells, causes autosomal-recessive hearing impairment". American Journal of Human Genetics. 91 (4): 636–645. doi:10.1016/j.ajhg.2012.08.018. PMC 3484643. PMID 22981119.
  11. ↑ Oestreicher D, Picher MM, Rankovic V, Moser T, Pangrsic T (2021). "Cabp2-Gene Therapy Restores Inner Hair Cell Calcium Currents and Improves Hearing in a DFNB93 Mouse Model". Frontiers in Molecular Neuroscience. 14 689415. doi:10.3389/fnmol.2021.689415. PMC 8417311. PMID 34489639.
  12. ↑ Sheyanth IN, Højland AT, Okkels H, Lolas I, Thorup C, Petersen MB (April 2021). "First reported CABP2-related non-syndromic hearing loss in Northern Europe". Molecular Genetics & Genomic Medicine. 9 (4) e1639. doi:10.1002/mgg3.1639. PMC 8123739. PMID 33666369.